Corticosteroid-associated avascular necrosis: Dose relationships and early diagnosis

Annals of the New York Academy of Sciences

Volumn 1240, Issue 1, 2011, Pages 38-46

  Aaron, Roy K ^a   Voisinet, Anne ^a   Racine, Jennifer ^a   Ali, Yousaf ^b   Feller, Edward R ^a  

^a BROWN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Avascular necrosis; Corticosteroids; Renal transplant; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADIPOGENESIS; APOPTOSIS; ARTICLE; AVASCULAR NECROSIS; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EXPOSURE; EARLY DIAGNOSIS; EARLY INTERVENTION; ENTERITIS; HIGH RISK PATIENT; HIP DISEASE; HUMAN; KIDNEY TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; OSTEOLYSIS; RESPIRATORY TRACT DISEASE; RHEUMATIC DISEASE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRABECULAR BONE; TREATMENT DURATION;

EID: 83755182754     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06218.x     Document Type: Article

References (73)

1. Mankin, H.J. 1992. Nontraumatic necrosis of bone (osteonecrosis). N. Engl. J. Med. 326: 1473-1479.
2. Zizic, T.M. 1985. Avascular necrosis of bone. In Textbook of Rheumatology. H.E. Kelly, W.N., S. Ruddy, et al., Eds.: 1689-1710. WB Saunders. Philadelphia, PA.
3. Ono, K.S.Y. 1993. Epidemiology and risk factors in avascular necrosis of the femoral head. In Bone Circulation and Vascularization in Normal and Pathologic Conditions. A.J. Schoutens & J.W.M. Gardeniers, et al., Eds.: 243-248. Plenum Press. New York, NY.
4. Boettcher, W.G. et al. 1970. Non-traumatic necrosis of the femoral head. I. Relation of altered hemostasis to etiology. J. Bone Joint Surg. Am. 52: 312-321.
5. Hauzeur, J.P., J.L. Pasteels & S. Orloff. 1987. Bilateral non-traumatic aseptic osteonecrosis in the femoral head. An experimental study of incidence. J. Bone Joint Surg. Am. 69: 1221-1225.
6. Jacobs, B. 1978. Epidemiology of traumatic and nontraumatic osteonecrosis. Clin. Orthop. Relat. Res. 130: 51-67.
7. Marcus, N.D., W.F. Enneking & R.A. Massam. 1973. The silent hip in idiopathic aseptic necrosis. Treatment by bone-grafting. J. Bone Joint Surg. Am. 55: 1351-1366.
8. Patterson, R.J., W.H. Bickel & D.C. Dahlin. 1964. Idiopathic avascular necrosis of the head of the femur. A study of fifty-two cases. J. Bone Joint Surg. Am. 46: 267-282.
9. Bradway, J.K. & B.F. Morrey. 1993. The natural history of the silent hip in bilateral atraumatic osteonecrosis. J. Arthroplasty 8: 383-387.
10. Vakil, N. & M. Sparberg. 1989. Steroid-related osteonecrosis in inflammatory bowel disease. Gastroenterology 96: 62-67.
11. Cruess, R.L. 1981. Steroid-induced osteonecrosis. J. R. Coll. Surg. Edinb. 26: 69-77.
12. Bradbury, G. et al. 1994. Avascular necrosis of bone after cardiac transplantation. Prevalence and relationship to administration and dosage of steroids. J. Bone Joint Surg. Am. 76: 1385-1388.
13. Atsumi, T. & Y. Kuroki. 1992. Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin. Orthop. Relat. Res. 277: 22-30.
14. Barnes, R. et al. 1976. Subcapital fractures of the femur. A prospective review. J. Bone Joint Surg. Br. 58: 2-24.
15. Bauer, T.A.S.B. 1993. The histology of osteonecrosis and its distinction from histologic artifacts. In Bone Circulation and Vascularization in Normal and Pathological Conditions. A.J. Schoutens & J.W.M. Gardeniers, et al., Eds.: 283-292. Plenum. New York, NY.
16. Berger, C.E. et al. 2000. Elevated levels of lipoprotein(a) in familial bone marrow edema syndrome of the hip. Clin. Orthop. Relat. Res. 377: 126-131.
17. Jones, J.P., Jr. 1994. Concepts of etiology and early pathogenesis of osteonecrosis. Instr. Course Lect. 43: 499-512.
18. Felson, D.T. & J.J. Anderson. 1987. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet 1: 902-906.
19. Wolverton, S.E. 1995. Major adverse effects from systemic drugs: defining the risks. Curr. Probl. Dermatol. 7: 6-38.
20. Weiner, E.S. & M. Abeles. 1989. Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation. J. Rheumatol. 16: 604-608.
21. Nagasawa, K. et al. 1989. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann. Rheum. Dis. 48: 672-676.
22. Powell, C. et al. 2010. Steroid induced osteonecrosis: an analysis of steroid dosing risk. Autoimmun. Rev. 9: 721-743.
23. Zizic, T.M. et al. 1985. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am. J. Med. 79: 596-604.
24. Massardo, L. et al. 1992. High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus. Lupus 1: 401-405.
25. Ono, K., T. Tohjima & T. Komazawa. 1992. Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy. Clin. Orthop. Relat. Res. 277: 89-97.
26. Zonana-Nacach, A. et al. 2000. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum. 43: 1801-1808.
27. Oinuma, K. et al. 2001. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann. Rheum. Dis. 60: 1145-1148.
28. Mont, M.A. et al. 1997. Risk factors for osteonecrosis in systemic lupus erythematosus. J. Rheumatol. 24: 654-662.
29. Uea-areewongsa, P. et al. 2009. Factors associated with osteonecrosis in Thai lupus patients: a case control study. J. Clin. Rheumatol. 15: 345-349.
30. Landmann, J. et al. 1987. Cyclosporin A and osteonecrosis of the femoral head. J. Bone Joint Surg. Am. 69: 1226-1228.
31. Tang, S. et al. 2000. Risk factors for avascular bone necrosis after renal transplantation. Transplant. Proc. 32: 1873-1875.
32. Lausten, G.S., J.S. Jensen & K. Olgaard. 1988. Necrosis of the femoral head after renal transplantation. Acta Orthop. Scand. 59: 650-654.
33. Metselaar, H.J. et al. 1985. Incidence of osteonecrosis after renal transplantation. Acta Orthop. Scand. 56: 413-415.
34. Khanna, A.J. et al. 2000. Femoral head osteonecrosis: detection and grading by using a rapid MR imaging protocol. Radiology 217: 188-192.
35. Matsuo, K. et al. 1988. Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head. Clin. Orthop. Relat. Res. 234: 115-123.
36. Houssiau, F.A. et al. 1998. Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodies. Br. J. Rheumatol. 37: 448-453.
37. Mok, M.Y., V.T. Farewell & D.A. Isenberg. 2000. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann. Rheum. Dis. 59: 462-467.
38. Gladman, D.D. et al. 2001. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J. Rheumatol. 28: 761-765.
39. Asherson, R.A. et al. 1993. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J. Rheumatol. 20: 284-288.
40. Hirata, T. et al. 2007. Low molecular weight phenotype of Apo(a) is a risk factor of corticosteroid-induced osteonecrosis of the femoral head after renal transplant. J. Rheumatol. 34: 516-522.
41. Aaron, R.K. & D.M. Ciombor. 2001. Coagulopathies and osteonecrosis. Curr. Opin. Orthop. 12: 378-383.
42. Aaron, R.K., J. Sweeney, L. Bausserman, et al. 2011. Coagulapothies in Avascular Necrosis of the Hip. The Warren Alpert Medical School of Brown University. Providence, RI. In press.
43. Aaron, R.K. & R. Gray. 2007. Osteonecrosis: etiology, natural history, pathophysiology, and diagnosis. In The Adult Hip. Volume 1. J.J. Callaghan, A.G. Rosenberg, H.E. Rubash, Eds.: 465-476. Lippincott Williams & Wilkins. Philadelphia, PA.
44. Bonfiglio, M. 1976. Development of bone necrosis lesions. In Underwater Physiology. V.C. Lambertsen, Ed.: 117-132. Federation of American Societies for Experimental Biology. Bethesda, MD.
45. Ficat, R.a.A., J. 1980. Functional investigation of bone under normal conditions. In Ischemia and Necrosis of Bone. D.S. Hungerford, Ed.: 29-52. Williams & Wilkins. Baltimore, MD.
46. Jones, J.P., Jr. 1992. Intravascular coagulation and osteonecrosis. Clin. Orthop. Relat. Res. 277: 41-53.
47. Saito, S., K. Ohzono & K. Ono. 1992. Early arteriopathy and postulated pathogenesis of osteonecrosis of the femoral head. The intracapital arterioles. Clin. Orthop. Relat. Res. 277: 98-110.
48. Spencer, J.D. & M. Brookes. 1988. Avascular necrosis and the blood supply of the femoral head. Clin. Orthop. Relat. Res. 235: 127-140.
49. James, J. & G.L. Steijn-Myagkaya. 1986. Death of osteocytes. Electron microscopy after in vitro ischaemia. J. Bone Joint Surg. Br. 68: 620-624.
50. Jones, J.P., Jr., 1985. Osteonecrosis. In Arthritis and Allied Conditions. D. McCarty, Ed.: 1356-1373. Lea & Febiger. Philadelphia, PA.
51. Kenzora, J.E., M.J. Glimcher. 1981. Osteonecrosis. In Textbook of Rheumatology, H.E. Kelly W.N., S. Ruddy et al., Eds.: 1755-1782. WB Saunders. Philadelphia, PA.
52. Saito, S., A. Inoue & K. Ono. 1987. Intramedullary haemorrhage as a possible cause of avascular necrosis of the femoral head. The histology of 16 femoral heads at the silent stage. J. Bone Joint Surg. Br. 69: 346-351.
53. Glimcher, M.J. & J.E. Kenzora. 1979. Nicolas Andry award. The biology of osteonecrosis of the human femoral head and its clinical implications: 1. Tissue biology. Clin. Orthop. Relat. Res. 138: 284-309.
54. Jones, J.P., Jr. 1991. Etiology and pathogenesis of osteonecrosis. Semin. Arthroplasty 2: 160-168.
55. Catto, M. 1965. A histological study of avascular necrosis of the femoral head after transcervical fracture. J. Bone Joint Surg. Br. 47: 749-776.
56. Glimcher, M.J. & J.E. Kenzora. 1979. The biology of osteonecrosis of the human femoral head and its clinical implications: II. The pathological changes in the femoral head as an organ and in the hip joint. Clin. Orthop. Relat. Res. 139: 283-312.
57. Glimcher, M.J. & J.E. Kenzora. 1979. The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; comments on treatment. Clin. Orthop. Relat. Res. 140: 273-312.
58. Brown, T.D., K.J. Baker & R.A. Brand. 1992. Structural consequences of subchondral bone involvement in segmental osteonecrosis of the femoral head. J. Orthop. Res. 10: 79-87.
59. Aaron, R.K., B.N. Stulberg & D.W. Lennox. 2001. Clinical and radiographic outcomes in untreated symptomatic osteonecrosis of the femoral head. Tech. Orthop. 16: 1-5.
60. Aaron, R.K., B.N. Stulberg & D.W. Lennox. 1997. The natural history of osteonecrosis of the femoral head and risk factors for progression. In The Etiology, Diagnosis and Management of Osteonecrosis of the Human Skeleton. J.R. Urbaniak, Ed.: 261-265. American Academy of Orthopaedic Surgeons. Chicago, IL.
61. Kerachian, M.A., C. Séguin & E.J. Harvey. 2009. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J. Steroid Biochem. Mol. Biol. 114: 121-128.
62. Wang, G.J., Q. Cui & G. Balian. 2000. The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin. Orthop. Relat. Res. 370: 295-310.
63. Kawai, K., A. Tamaki & K. Hirohata. 1985. Steroid-induced accumulation of lipid in the osteocytes of the rabbit femoral head. A histochemical and electron microscopic study. J. Bone Joint Surg. Am. 67: 755-763.
64. Wang, G.J. et al. 1981. Cortisone-induced intrafemoral head pressure change and its response to a drilling decompression method. Clin. Orthop. Relat. Res. 159: 274-278.
65. Wang, G.J. et al. 1977. Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J. Bone Joint Surg. Am. 59: 729-735.
66. Cui, Q., G.J. Wang & G. Balian. 1997. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. J. Bone Joint Surg. Am. 79: 1054-1063.
67. Wang, G.J. & Q. Cui. 1997. The pathogenesis of steroid-induced osteonecrosis and the effect of lipid-clearing agents on this mechanism. In The Pathogenesis of Steroid-Induced Osteonecrosis and the Effect of Lipid-Clearing Agents on this Mechanism. J.R. Urbaniak, & J.P. Jones, Eds.: 159-166. American Academy of Orthopaedic Surgeons. Rosemont, IL.
68. Wang, Y. et al. 2003. Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin. Orthop. Relat. Res. 410: 213-224.
69. Steinberg, M.E., G.D. Hayken & D.R. Steinberg. 1995. A quantitative system for staging avascular necrosis. J. Bone Joint Surg. Br. 77: 34-41.
70. Marston, S.B. et al. 2002. Osteonecrosis of the femoral head after solid organ transplantation: a prospective study. J. Bone Joint Surg. Am. 84-A: 2145-2151.
71. Aaron, R.K. et al. 1989. The conservative treatment of osteonecrosis of the femoral head. A comparison of core decompression and pulsing electromagnetic fields. Clin. Orthop. Relat. Res. 249: 209-218.
72. Mont, M.A. & D.S. Hungerford. 1995. Non-traumatic avascular necrosis of the femoral head. J. Bone Joint Surg. Am. 77: 459-474.
73. Agarwala, S. et al. 2005. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology (Oxford) 44: 352-359.